Signe Sorensen Torekov
Overview
Explore the profile of Signe Sorensen Torekov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Holt R, Holt J, Jorsal M, Sandsdal R, Jensen S, Byberg S, et al.
J Clin Endocrinol Metab
. 2024 Nov;
PMID: 39530599
Context: Obesity is associated with low vitamin D and recent studies have suggested a difference in vitamin D metabolism between females and males. Objective: The aim of this study was...
2.
Jensen S, Sorensen V, Sandsdal R, Lehmann E, Lundgren J, Juhl C, et al.
JAMA Netw Open
. 2024 Jun;
7(6):e2416775.
PMID: 38916894
Importance: A major concern with weight loss is concomitant bone loss. Exercise and glucagon-like peptide-1 receptor agonists (GLP-1RAs) represent weight loss strategies that may protect bone mass despite weight loss....
3.
Quist J, Pedersen H, Jensen M, Clemmensen K, Bjerre N, Ekblond T, et al.
Lancet Healthy Longev
. 2024 Apr;
5(5):e314-e325.
PMID: 38588687
Background: Time-restricted eating (TRE) has been suggested to be a simple, feasible, and effective dietary strategy for individuals with overweight or obesity. We aimed to investigate the effects of 3...
4.
Jensen S, Baek Blond M, Sandsdal R, Olsen L, Juhl C, Lundgren J, et al.
EClinicalMedicine
. 2024 Mar;
69:102475.
PMID: 38544798
Background: New obesity medications result in large weight losses. However, long-term adherence in a real-world setting is challenging, and termination of obesity medication results in weight regain towards pre-treatment body...
5.
Mullertz A, Sandsdal R, Jensen S, Torekov S
Obes Rev
. 2024 Mar;
25(5):e13717.
PMID: 38463003
Potent incretin-based therapy shows promise for the treatment of obesity along with reduced incidence of cardiovascular events in patients with preexisting cardiovascular disease and obesity. This study assessed the efficacy...
6.
Bojsen-Moller K, Svane M, Martinussen C, Dirksen C, Jorgensen N, Jensen J, et al.
Int J Obes (Lond)
. 2023 Aug;
47(11):1143-1151.
PMID: 37653071
Background/objectives: After Roux-en-Y gastric bypass (RYGB) a subset of patients never obtain excess BMI loss (EBMIL) > 50% and are categorized as having primary weight loss (WL) failure. We hypothesized...
7.
Brethvad A, Zakariassen H, Holt J, Lundgren J, Jakobsen A, Hartmann B, et al.
Metabolism
. 2023 Mar;
143:155534.
PMID: 36933790
Background: The gut derived anorexigenic hormone neurotensin (NT) is upregulated after bariatric surgery which may contribute to the sustained weight loss. In contrast, diet-induced weight loss is most often followed...
8.
Jensen S, Janus C, Lundgren J, Juhl C, Sandsdal R, Olsen L, et al.
Nat Commun
. 2022 Aug;
13(1):4770.
PMID: 35970829
Weight regain after weight loss remains a major challenge in obesity treatment and may involve alteration of eating and sedentary behavior after weight loss. In this randomized, controlled, double-blind trial,...
9.
Termannsen A, Clemmensen K, Thomsen J, Norgaard O, Diaz L, Torekov S, et al.
Obes Rev
. 2022 Jun;
23(9):e13462.
PMID: 35672940
In parallel with an increased focus on climate changes and carbon footprint, the interest in plant-based diets and its potential health effects have increased over the past decade. The objective...
10.
Lehmann E, Torekov S
Cardiovasc Res
. 2021 Aug;
117(10):e120-e122.
PMID: 34448813
No abstract available.